You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ramucirumab

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastroesophageal Adenocarcinoma Trial (Paclitaxel, Ramucirumab, Zanidatamab)

Not yet recruiting
  • Gastroesophageal Adenocarcinoma
  • (no location specified)
Sep 12, 2023

Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • TRK-950
  • +2 more
  • Chuo Ku, Japan
    Osaka International Cancer Institute
Sep 14, 2023

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Non Small Cell Lung Cancer, Metastatic, Recurrent Trial in United States (Lorlatinib, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • Middletown, New Jersey
  • +5 more
Aug 17, 2023

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial (Ramucirumab, Paclitaxel)

No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jan 17, 2023

Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, other, procedure)

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Ramucirumab
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 21, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (Chemotherapy, Pembrolizumab, Ramucirumab)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • (no location specified)
Jan 9, 2023

Gastric Adenocarcinoma Trial in Guangzhou (Sintilimab, Ramucirumab, Cisplatin)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 10, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, biological, drug)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Sep 7, 2023

Carcinoid Tumors Trial in Boston (Ramucirumab, Somatostatin Analog)

Active, not recruiting
  • Carcinoid Tumors
  • Ramucirumab
  • Somatostatin Analog
  • Boston, Massachusetts
  • +1 more
Apr 14, 2022

Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)

Recruiting
  • Neoplasms
  • +2 more
  • Ramucirumab
  • +7 more
  • Leiden, Netherlands
    Leids Universitair Medisch Centrum
Aug 14, 2023

Non Small Cell Lung Cancer Trial in Philadelphia (Nivolumab, Ramucirumab)

Recruiting
  • Non Small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Apr 6, 2022

Gastric Adenocarcinoma, Metastatic Adenocarcinoma of the Gastroesophageal Junction Trial in Germany (Ramucirumab, TAS 102)

Active, not recruiting
  • Gastric Adenocarcinoma
  • Metastatic Adenocarcinoma of the Gastroesophageal Junction
  • Ramucirumab
  • TAS 102
  • Frankfurt, Germany
  • +4 more
Mar 2, 2022

NSCLC Trial in Philadelphia (Carboplatin, Paclitaxel, Ramucirumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 14, 2022

NSCLC Stage IB, NSCLC Stage II, NSCLC Stage ?A Trial in Kashiwa, Shinjuku-Ku (Pembrolizumab, Ramucirumab, Surgery)

Recruiting
  • Non-small Cell Lung Cancer Stage IB
  • +2 more
  • Kashiwa, Chiba, Japan
  • +1 more
Apr 4, 2022

Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Metastatic Non-Small Lung Cell Cancer
  • +4 more
  • Atlanta, Georgia
    Winship Cancer Institute of Emory University
Oct 19, 2022

Non Small Cell Lung Cancer Trial in Tampa, Houston (quaratusugene ozeplasmid, pembrolizumab, docetaxel)

Recruiting
  • Non Small Cell Lung Cancer
  • quaratusugene ozeplasmid
  • +3 more
  • Tampa, Florida
  • +2 more
Sep 12, 2022

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Nov 30, 2022

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Gastric Cancer, Esophageal Cancer, Gastro-esophageal Cancer Trial in Taiwan, United States (Oraxol, Ramucirumab)

Unknown status
  • Gastric Cancer
  • +2 more
  • San Antonio, Texas
  • +4 more
Feb 15, 2022

Pancreatic Cancer Trial in United States (mFOLFIRINOX, Ramucirumab, Placebo)

Active, not recruiting
  • Pancreatic Cancer
  • Scottsdale, Arizona
  • +7 more
Feb 14, 2022

NSCLC, Non-small Cell Carcinoma, NSCLC Trial (Ramucirumab, Atezolizumab, N-803)

Withdrawn
  • Non-small Cell Lung Cancer
  • +3 more
  • Ramucirumab
  • +2 more
  • (no location specified)
Oct 28, 2021

Esophagus Cancer, Adenocarcinoma, Stomach Cancer, Adenocarcinoma Trial in United States (Rucaparib, Ramucirumab, Nivolumab)

Recruiting
  • Esophagus Cancer, Adenocarcinoma
  • Stomach Cancer, Adenocarcinoma
  • Chicago, Illinois
  • +7 more
Jan 31, 2022

Advanced Solid Tumor Trial in Japan, United States (Ramucirumab)

Terminated
  • Advanced Solid Tumor
  • Ramucirumab
  • Fayetteville, Arkansas
  • +4 more
Aug 31, 2021

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Worldwide (tucatinib,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Birmingham, Alabama
  • +47 more
Oct 27, 2022